Tiziana Life Sciences Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +722.1% | -97.7% | +21.5% | +49.7% | +1,118.3% | -66.1% | +58.5% | -60.2% | +82.7% | +30.4% | +136.2% | |
| – | +832.1% | -73.7% | -41.6% | +9.5% | +62.2% | +291.8% | +1.5% | -127.3% | – | -17.6% | -20.2% | |
| – | +182.9% | -64.7% | -215.5% | – | +44.9% | +654.1% | -84.8% | -235.8% | – | – | – | |
| – | -145.4% | – | +86.7% | +9.2% | -88.5% | -196.5% | – | – | – | – | – | |
| – | +722.1% | -97.7% | -97.5% | -99.9% | +227,609.9% | -36.7% | +764.2% | -100.0% | – | – | +38.3% | |
| – | -484.0% | +9.9% | -99.6% | -18.8% | +278.3% | +3,028.0% | – | -3,480.4% | -69.6% | -94.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -65.2% | -82.8% | +164.5% | +615.3% | -82.8% | – | – | – | – | – | – | |
| – | -29.1% | -93.1% | +137.0% | +0.0% | +0.0% | -106.8% | +33.3% | -63.8% | +116.4% | +18.5% | +39.0% | |
| – | +174.8% | -89.8% | -8.9% | +767.1% | -87.0% | +4,038.5% | -100.0% | +163.0% | – | +11,272.7% | +178.0% | |
| – | +203.6% | -191.8% | – | – | -175.9% | – | -136.4% | – | – | – | -85.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.